Spin-off - Passley Shaun

Form Type: SCHEDULE 13D

Filing Date: 2025-01-21

Corporate Action: Spin-off

Type: Update

Accession Number: 000137647425000097

Filing Summary: This Schedule 13D relates to the common shares of ZenaTech Inc., a British Columbia corporation. Dr. Shaun Passley, along with Epazz, Inc. and Ameritek Ventures, Inc., filed this statement to disclose their collective ownership and control of ZenaTech's common shares. Passley, as the principal shareholder of both Epazz and Ameritek, maintains significant voting control over the shares held by these entities. The document highlights that Epazz was the former parent company of ZenaTech and that ZenaTech was spun off in November 2018. At the time of the spin-off, Epazz received 4,967,300 shares, and Dr. Passley received 4,836,460 shares of ZenaTech. Recently, in January 2022, ZenaTech acquired technology from Ameritek in exchange for 583,333 common shares. The filings indicate that the reporting persons do not have immediate plans that would significantly affect their investments or control of ZenaTech. Passley holds approximately 22% of ZenaTech's outstanding shares, while Epazz and Ameritek hold approximately 24% and 2% respectively. Furthermore, it was noted that Dr. Passley sold 45,447 common shares on January 3, 2025, in compliance with Rule 144.